Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FKELU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,249
Award facts
- Contract value 100% obligated
- $6,248.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $6,248.70 to DMS Pharmaceutical Group Inc. for Nexplanon 68 mg implants on September 12, 2025, with an ultimate completion date of October 3, 2025. The contract represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 through November 2026.
Nexplanon is a subdermal contraceptive implant used in military and federal healthcare systems. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure extensive contracts for pharmaceutical products and medical supplies serving Department of Defense healthcare facilities worldwide. The company's portfolio includes delivery orders for prescription medications, biologics, vaccines, and specialized pharmaceutical products across multiple therapeutic categories. This award reflects the contractor's continued role in supporting the Defense Logistics Agency's pharmaceutical supply requirements for military health facilities.
Quick answers
Who was awarded contract SPE2DB25FKELU?
SPE2DB25FKELU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FKELU worth?
The government has obligated $6,249 on SPE2DB25FKELU.
Is contract SPE2DB25FKELU an order under another contract?
Yes. SPE2DB25FKELU is a delivery order under SPE2DB24D9223, an indefinite delivery contract.
Was contract SPE2DB25FKELU competed?
The extent of competition for SPE2DB25FKELU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award